Clinical trial
Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICDs Study
NCT00231426 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICDs Study
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2003
- Completion date
- November 30, 2005
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tachyarrhythmia